LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
SY
So-Young International Inc.
There isn't enough reported data to score SY yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
SY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Strong |
SY's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
SY PE Valuation
SY has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
SY Forward outlook
There aren't enough analyst estimates for SY to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over SY on earnings quality, reporting a profit while its opponent remains loss making.
SY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.28 | +$0.46 |
| Q1 2026 | -$0.29 | +$0.39 |
| Q4 2025 | -$0.27 | +$0.39 |
| Q3 2025 | -$0.84 | -2200% |
| Q2 2025 | -$0.74 | -1950% |
| Q1 2025 | -$0.68 | -6900% |
| Q4 2024 | -$0.66 | -3400% |
| Q3 2024 | $0.04 | 0% |
SY lost $0.28 per share over the past year, a smaller loss than the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over SY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over SY on profitability, with a higher operating margin.
SY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $75.6M | +33% |
| Q1 2026 | $64.6M | +45% |
| Q4 2025 | $68.2M | +23% |
| Q3 2025 | $58M | +4% |
| Q2 2025 | $56.8M | -7% |
| Q1 2025 | $44.6M | -6.6% |
| Q4 2024 | $55.4M | -5.5% |
| Q3 2024 | $55.8M | -3.5% |
SY's revenue has grown year over year for four quarters in a row: $76M last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.6% | +3.8 points |
| Q1 2026 | -13% | +1.2 points |
| Q4 2025 | -22% | +140 points |
| Q3 2025 | -19% | -20 points |
| Q2 2025 | -12% | -14 points |
| Q1 2025 | -15% | -3 points |
| Q4 2024 | -162% | -161 points |
| Q3 2024 | 1.3% | +1.8 points |
SY's operating margin was −8.6% last quarter, up 3.8 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with SY at down 1,200%.
SY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$45.3M | -$45.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
| Q2 2024 | $0 | $0 |
SY's free cash flow was −$45M over the past year, against $0 the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over SY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
SY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +187K shares |
| 1 year | -0.1% | -75.7K shares |
| 3 years | +0.6% | +796K shares |
| 5 years | -6.3% | -8.9M shares |
| Available history | -6.2% | -8.6M shares |
SY has 131M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | $2.3M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
SY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -73.4x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -4.1x | Net Cash |
| Q1 2024 | -6.3x | Net Cash |
| Q4 2023 | -5.1x | Net Cash |
| Q3 2023 | -5.3x | Net Cash |
| Q2 2023 | -17.6x | Net Cash |
| Q1 2023 | -141.9x | Net Cash |
SY has more cash than debt.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
SY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 12.9 | Oversold |
SY's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
SY PE vs Healthcare Sector
| Metric | SY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SY has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over SY on trend strength, trading above more of its moving averages.
SY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.29 | 15% below |
| 20 week MA | $2.22 | 13% below |
| 50 week MA | $2.50 | 22% below |
| 100 week MA | $2.35 | 17% below |
| 200 week MA | $1.88 | 3.2% above |
SY has fallen below most of its moving averages, though it's still 3.2% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over SY on returns for 2026, with the stronger performance.
SY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.9 | $11.4 | -4.4% |
| 2021 | $11.4 | $3.13 | -73% |
| 2022 | $3.13 | $1.39 | -56% |
| 2023 | $1.39 | $1.29 | -7.2% |
| 2024 | $1.29 | $0.82 | -36% |
| 2025 | $0.82 | $2.63 | +221% |
| 2026 YTD | $2.63 | $1.94 | -26% |
SY's yearly returns have swung widely, from +221% in 2025 to −73% in 2021. It's down 26% so far in 2026.